Biblio

Filters: Author is Gepstein, Lior [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C

Budniatzky I, Gepstein L. Concise Review: Reprogramming Strategies for Cardiovascular Regenerative Medicine: From Induced Pluripotent Stem Cells to Direct Reprogramming. Stem Cells Transl Med. 2014.

E

Goldfracht I, Efraim Y, Shinnawi R, Kovalev E, Huber I, Gepstein A, Arbel G, Shaheen N, Tiburcy M, Zimmerman WH, et al. Engineered Heart Tissue Models from hiPSC-Derived Cardiomyocytes and Cardiac ECM for Disease Modeling and Drug Testing Applications. Acta Biomater. 2019.

I

Shinnawi R, Gepstein L. iPCS Cell Modeling of Inherited Cardiac Arrhythmias. Curr Treat Options Cardiovasc Med. 2014;16(9):331.

M

Shinnawi R, Huber I, Maizels L, Shaheen N, Gepstein A, Arbel G, Tijsen AJ, Gepstein L. Monitoring Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Genetically Encoded Calcium and Voltage Fluorescent Reporters. Stem Cell Reports. 2015.

T

de Boer RA, Heymans S, Backs J, Carrier L, Coats AJS, Dimmeler S, Eschenhagen T, Filippatos G, Gepstein L, Hulot J-S, et al. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: From molecular mechanisms to therapeutic targets. Eur J Heart Fail. 2021.

Wu JC, Garg P, Yoshida Y, Yamanaka S, Gepstein L, Hulot J-S, Knollmann BC, Schwartz PJ. Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies. Circ Res. 2019;125(6):653-658.